Eupraxia Pharmaceuticals Provides Update for Phase 2 Study in Knee Osteoarthritis for Lead Drug Candidate EP-104IAR Life Science Investing
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting Pharmaceutical Investing
Allergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting Pharmaceutical Investing
Bristol Myers Squibb Announces Change to Earnings Conference Call Dial-In Information for Third Quarter 2022 Results Scheduled for October 26, 2022 Pharmaceutical Investing
AMGEN OPENS NEW STATE-OF-THE-ART RESEARCH AND DEVELOPMENT LABORATORY SITE IN SAN FRANCISCO BAY AREA Market News
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA Life Science Investing
Mindset Pharma Selects Lead Clinical Candidates From "Family 2" of its Next Generation Psychedelic Drug Portfolio Life Science Investing
Ginkgo Bioworks Acquires Circularis to Strengthen Capabilities in Cell and Gene Therapy Life Science Investing
